SG
Srinivasarao Gummadidala
About Srinivasarao Gummadidala
Data last updated:
Srinivasarao Gummadidala is a Director at Lakshmi Narsimha Diagnostics & Healthcare Private Limited (since 2024) and Director at Veenuz Medical Diagnostics Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Lakshmi Narsimha Diagnostics & Healthcare Private Limited at ₹4.67 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Nov 2024 | 2024 | ₹4.67 Cr (FY 2025) | Active | |
| Director | 16 Apr 2025 | 2025 | Active |
Board colleagues of Srinivasarao Gummadidala
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasarao Gummadidala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasarao Gummadidala
Srinivasarao Gummadidala currently holds 2 directorships: Lakshmi Narsimha Diagnostics & Healthcare Private Limited (Director, since 19 Nov 2024, revenue ₹4.67 Cr (FY 2025)); Veenuz Medical Diagnostics Private Limited (Director, since 16 Apr 2025).
Srinivasarao Gummadidala was first appointed on 19 Nov 2024 as Director at Lakshmi Narsimha Diagnostics & Healthcare Private Limited. The most recent appointment on record is 16 Apr 2025 at Veenuz Medical Diagnostics Private Limited.
The current boards of Srinivasarao Gummadidala's companies include Praveena Derangula (Lakshmi Narsimha Diagnostics & Healthcare Private Limited), Sreelakshmi Bharathala (Lakshmi Narsimha Diagnostics & Healthcare Private Limited), Venkatesh Kumar Rachaputi (Lakshmi Narsimha Diagnostics & Healthcare Private Limited), Chithirala Alekhya (Veenuz Medical Diagnostics Private Limited), Lavanya Chinthalapudi (Veenuz Medical Diagnostics Private Limited).